[1]Longhini F, Bruni A, Garofalo E, et al. Anesthetic strategies in oncological surgery: not only a simple sleep, but also impact on immunosuppression and cancer recurrence[J]. Cancer Manag Res, 2020, 12: 931-940. [2]Wang X, Xie W, Gan S, et al. Effects of general anesthesia versus local anesthesia in primary hepatocellular carcinoma patients presenting for thermal ablation surgery: a multiple center retrospective cohort study with propensity score matching[J]. Ann Transl Med, 2020, 8: 277.doi:10.21037/atm.2020.03.88. [3]Koumpan Y, Jaeger M, Mizubuti GB, et al. Spinal anesthesia is associated with lower recurrence rates after resection of nonmuscle invasive bladder cancer[J]. J Urol, 2018, 199: 940-946. [4]Pei JP, Zhang CD, Liang Y, et al. Effects of epidural combined with general anesthesia versus general anesthesia alone in gastric cancer surgery: a propensity score matching analysis[J]. Ann Transl Med, 2020, 8: 473.doi:10.21037/atm.2020.03.127. [5]Chen DT, Pan JH, Chen YH, et al. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target[J]. Br J Anaesth, 2019, 122: e157-e167. [6]Silagy AW, Hannum ML, Mano R, et al. Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia[J]. Br J Anaesth, 2020, 125: e402-e404. [7]MacFater WS, Xia W, Barazanchi A, et al. Intravenous local anaesthetic compared with intraperitoneal local anaesthetic in abdominal surgery: a systematic review[J]. World J Surg, 2018, 42: 3112-3119. [8]Zhang H, Yang L, Zhu X, et al. Association between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study[J]. Br J Anaesth, 2020, 125: 141-148. [9]Djamgoz MBA, Fraser SP, Brackenbury WJ. In vivo evidence for voltage-gated sodium channel expression in carcinomas and potentiation of metastasis[J]. Cancers, 2019, 11: 1675.doi:10.3390/cancers11111675. [10]Baptista-Hon DT, Robertson FM, Robertson GB, et al. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1.5 channel function[J]. Br J Anaesth, 2014, 113: i39-i48. [11]Yildirim S, Altun S, Gumushan H, et al. Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo[J]. Cancer Lett, 2012, 323: 58-61. [12]Elajnaf T, Baptista-Hon DT, Hales TG. Potent inactiva-tion-dependent inhibition of adult and neonatal NaV1.5 channels by lidocaine and levobupivacaine[J]. Anesth Analg, 2018, 127: 650-660. [13]Masui K, Harachi M, K. Cavenee W, et al. Codepen-dency of metabolism and epigenetics drives cancer progression: a review[J]. Acta Histochemica Et Cytochemica, 2020, 53: 1-10. [14]许力凡, 张记, 田志强, 等. 肿瘤抗药性的表观遗传学调控机制[J]. 基础医学与临床, 2013, 33: 1638-1640. [15]Tada M, Imazeki F, Fukai K, et al. Procaine inhibits the proliferation and DNA methylation in human hepatoma cells[J]. Hepatol Int, 2007, 1: 355-364. [16]Li K, Yang J, Han X. Lidocaine sensitizes the cytotoxi-city of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation[J]. Int J Mol Sci, 2014, 15: 23519-23536. [17]Lirk P, Hollmann MW, Fleischer M, et al. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro[J]. Br J Anaesth, 2014, 113: i32-i38. [18]Johnson MZ, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model[J]. Br J Anaesth, 2018, 121: 76-85. [19]Saito T, Yamamoto Y, Feng GG, et al. Lidocaine prevents oxidative stress-induced endothelial dysfunction of the systemic artery in rats with intermittent periodontal inflammation[J]. Anesth Analg, 2017, 124: 2054-2062. [20]Ortiz MP, Godoy MC, Schlosser RS, et al. Effect of endovenous lidocaine on analgesia and serum cytokines: double-blinded and randomized trial[J]. J Clin Anesth, 2016, 35: 70-77. [21]Othman AH, Ahmed DG, Abd El-Rahman AM, et al. Effect of preperitoneal versus epidural analgesia on postoperative inflammatory response and pain following radical cystectomy: a prospective, randomized trial[J]. Clin J Pain, 2019, 35: 328-334. [22]Hayden JM, Oras J, Block L, et al. Intraperitoneal ropivacaine reduces time interval to initiation of chemotherapy after surgery for advanced ovarian cancer: randomised controlled double-blind pilot study[J]. Br J Anaesth, 2020, 124: 562-570. [23]Cruz FF, Rocco PR, Pelosi P. Anti-inflammatory proper-ties of anesthetic agents[J]. Crit Care, 2017, 21: 67.doi:10.1186/s13054-017-1645-x. [24]Cata JP, Ramirez MF, Velasquez JF, et al. Lidocaine stimulates the function of natural killer cells in different experimental settings[J]. Anticancer Res, 2017, 37: 4727-4732. [25]Wang HL, Yan HD, Liu YY, et al. Intraoperative intravenous lidocaine exerts a protective effect on cell-mediated immunity in patients undergoing radical hysterectomy[J]. Mol Med Rep, 2015, 12: 7039-7044. [26]Wang L, Liang S, Chen H, et al. The effects of epidural anaesthesia and analgesia on T lymphocytes differentiation markers and cytokines in patients after gastric cancer resection[J]. BMC Anesthesiol, 2019, 19: 102.doi:10.1186/s12871-019-0778-7. |